David Schenkein, M.D.

David Schenkein, M.D.

DirectoratRegeneron Pharmaceuticals· In proxies 2023–2025

David Schenkein, M.D. sits on 9 public boards.

Experience

  1. Regeneron PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +14%
  2. Denali TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Agios PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Aera Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Agios Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Denali Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Leyden Labs, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Prime MedicinePublic company
    • Director? – PresentNo stock prices for these years
  9. Treeline BiosciencesPublic company
    • Director? – PresentNo stock prices for these years
  10. Bluebird BioPublic company
    • Director? – PresentNo stock prices for these years
  11. Foundation Medicine, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?